Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacia & Upjohn Rogaine sales grow 7% to $31 mil., Nicorette up 30% to $52 mil..

This article was originally published in The Tan Sheet

Executive Summary

PHARMACIA & UPJOHN ROGAINE SALES GROW 6.6% TO $30.9 MIL. in the first quarter, boosted by the U.S. introduction of OTC Rogaine Extra Strength for men (5% minoxidil), the company announced April 29. P&U launched the extra strength topical hair regrowth solution on New Year's Day ("The Tan Sheet" Jan. 5, p. 13). Rogaine Extra Strength has been spared the loss of exclusivity protection of regular Rogaine (2% minoxidil), which did not obtain Waxman/Hatch market exclusivity and was quickly joined by branded and private label competitors after its launch.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel